Editorial Commentary
Incremental innovation in endoscopic ultrasound-guided biopsy: does the tip make the difference?
Annals of Pancreatic Cancer
2026;
9:
25
.
(30 August 2026)
Editorial Commentary
Engineered exosomes silence oncogenic KRASG12D and awaken immunity in pancreatic cancer
Annals of Pancreatic Cancer
2026;
9:
24
.
(30 August 2026)
Editorial Commentary
Remodeling of tumour microenvironment of pancreatic cancer: can agonistic anti-CD40 antibodies give a new direction?
Annals of Pancreatic Cancer
2026;
9:
23
.
(30 August 2026)
Editorial Commentary
Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: interpreting the AGICC study
Annals of Pancreatic Cancer
2026;
9:
22
.
(30 August 2026)
Editorial Commentary
Precision immunotherapy in metastatic pancreatic cancer: OPTIMIZE-1 biomarker-driven patient stratification for future studies
Annals of Pancreatic Cancer
2026;
9:
21
.
(30 August 2026)
Editorial Commentary
18F-prostate specific membrane antigen positron emission tomography/computed tomography for pancreatic ductal adenocarcinoma: not specific enough
Annals of Pancreatic Cancer
2026;
9:
20
.
(30 August 2026)
Editorial Commentary
Targeting drug efflux in pancreatic cancer: what the PANTAX trial teaches us about resisting resistance
Annals of Pancreatic Cancer
2026;
9:
19
.
(30 August 2026)
Case Report
Double primary biliary malignancy: synchronous gallbladder carcinoma and extrahepatic cholangiocarcinoma in a Whipple specimen—a case report and literature review
Annals of Pancreatic Cancer
2026;
9:
18
.
(30 August 2026)
Case Report
ATP1B1::PRKACA fusion-defined intraductal oncocytic papillary neoplasm of the pancreas: a case report
Annals of Pancreatic Cancer
2026;
9:
17
.
(30 August 2026)
